Company Overview of Sanofi-Genzyme BioVentures
Sanofi-Genzyme BioVentures is a venture capital arm of Genzyme Corp. specializing in investments in growth capital. It only invests in early-stage life science companies. The firm prefers to invest in private biotech and healthcare companies; including rare diseases, oncology, vaccines, integrated health solutions and therapies. It prefers to invest globally with a focus on North America and Europe. The firm typically invests less than or equal to $5 million in a single round of financing and a maximum of $10 million in a single portfolio company for an equity ownership of less than 20 percent. It prefers to have an advisory committee membership, board observer or director positions or SAB m...
500 Kendall Street
Cambridge, MA 02142
Founded in 2001
Key Executives for Sanofi-Genzyme BioVentures
Vice President and Managing Director
Senior Director of Investments
Compensation as of Fiscal Year 2015.
Sanofi-Genzyme BioVentures Key Developments
Sanofi-Genzyme BioVentures Presents at BIO-Europe Spring 2015, Mar-09-2015 04:00 PM
Jan 29 15
Sanofi-Genzyme BioVentures Presents at BIO-Europe Spring 2015, Mar-09-2015 04:00 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France. Speakers: Bernard Davitian, Vice President and Managing Director.
Sanofi-Genzyme BioVentures Presents at BIO-Europe 2014, Nov-03-2014 09:00 AM
Oct 31 14
Sanofi-Genzyme BioVentures Presents at BIO-Europe 2014, Nov-03-2014 09:00 AM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany. Speakers: Ann DeWitt, Senior Director of Investments.
Sanofi-Genzyme BioVentures Presents at 2013 Therapeutic Area Partnerships Conference, Nov-19-2013 09:00 AM
Nov 15 13
Sanofi-Genzyme BioVentures Presents at 2013 Therapeutic Area Partnerships Conference, Nov-19-2013 09:00 AM. Venue: One Avenue De Lafayette, Boston, MA 02111, United States. Speakers: Bernard Davitian, Vice President of BD Licensing & Structured Investments and Managing Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries